- 51
- 53 303
Columbia University Technology Ventures
United States
Приєднався 5 кві 2017
Columbia Technology Ventures is the tech transfer office of Columbia University. Our core objective is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. Each year, CTV manages more than 330 invention disclosures from faculty, 70 license deals and 15 new start-ups, involving approximately 45 multi-disciplinary, full-time staff across Columbia's two campuses. CTV currently has over 1200 patent assets available for licensing, across research fields such as bio, IT, cleantech, devices, nanotechnology, and material science.
Columbia Technology Ventures has a particular focus on start-up companies. Over the years, CTV has been involved with launching over 150 companies based on Columbia's technologies. Of these companies, over 40 have received VC funding, with 27 successful acquisitions or IPOs to date.
Columbia Technology Ventures has a particular focus on start-up companies. Over the years, CTV has been involved with launching over 150 companies based on Columbia's technologies. Of these companies, over 40 have received VC funding, with 27 successful acquisitions or IPOs to date.
Developing a Business Plan and Securing Investors
Distinguished panelists Mark Leuchtenberger, MBA (President, CEO, IRX Therapeutics), Cameron Durrant, MD, MBA (Chairman and CEO, KaloBios Pharmaceuticals), and Ron Newbold, PhD, MBA (VP, External R&D Innovation, Pfizer) discuss the development of a business plan to bring early stage technologies through clinical development and into the marketplace. This fourth lecture of the Translational Therapeutics Seminar Series is moderated by Lorraine Marchand, MBA (Managing Partner, Centricity Health and Adjunct Professor at Columbia Business School).
Переглядів: 732
Відео
Dr. Andreas Hielscher
Переглядів 3007 років тому
Dr. Andreas H. Hielscher, Professor of Biomedical Engineering & Electrical Engineering in the Department of Biomedical Engineering, discusses his lab’s development of a blood flow imaging device for diagnosing peripheral artery disease, which has no other current diagnostic device, and as a real-time intraoperative tool for vascular surgeons. The project is seeking investors to transition from ...
Dr. Elisa Konofagou
Переглядів 1257 років тому
Dr. Elisa Konofagou, Professor of Biomedical Engineering and Radiology at CUMC, discusses her application of focused ultrasound to curb neuronal degeneration such as Alzheimers and Parkinsons disease. The project is seeking further investment to take these technologies to clinical trials through commercial partnerships that have been established.
Dr. Kartik Chandran
Переглядів 3647 років тому
Dr. Kartik Chandran, professor of Environmental Microbiology and Biotechnology at CUMC, explains Carbocycle, a startup that uses biological mechanisms to convert wastewater into synthetic palm oil for use in many products, including soap, cosmetics and detergent, as well as to produce clean energy and clean water sources. The group is looking to receive further funding to run pilot-scale system...
Dr. Andreas Hielscher (Promo Edit)
Переглядів 527 років тому
Dr. Andreas H. Hielscher, Professor of Biomedical Engineering & Electrical Engineering in the Department of Biomedical Engineering, discusses his lab’s development of a blood flow imaging device for diagnosing peripheral artery disease, which has no other current diagnostic device, and as a real-time intraoperative tool for vascular surgeons. The project is seeking investors to transition from ...
Q&A with Dan DeWolf
Переглядів 247 років тому
Co- Chair of Mintz Levin Venture Capital and Emerging Companies Practice offers advice for young entrepreneurs and early-stage companies.
Mintz Levin Lunch & Learn: Best Practices for Negotiating Commercial Licenses
Переглядів 2127 років тому
Watch Mintz Levin colleagues Julie Korostoff and Julia Siripurapu host a lunchtime presentation and q&a session on best practices for negotiating commercial licenses with large entities.
Regeneron: The Path from Basic Research to Commercial Product
Переглядів 18 тис.7 років тому
This first lecture in the Columbia Precision Medicine Initiative, Life Science Entrepreneurship seminar series, features a discussion with two of Regeneron’s leadership team: President and CSO George Yancopoulos, MD, PhD, and President and CEO of Regeneron, Leonard Schleifer, MD, PhD. The panel, moderated by the Director of the Columbia Precision Medicine Initiative Tom Maniatis, PhD, covers th...
Walker Digital: Perspectives on the Evolution of the U S Patent Landscape
Переглядів 1237 років тому
Remarks from Jay Walker & Jon Ellenthal of Walker Digital.
Prosecuting & Litigation European Patents
Переглядів 1587 років тому
Remarks from Fabrizio Jacobacci of Jacobacci Law.
Introductions to the Panelists
Переглядів 417 років тому
Part of a panel discussion with Laura Sheridan, Brian Hinman, Dan Abraham, and Bob Colao.
Managing Fortune 500 IP: Centralized vs Distributed Models
Переглядів 437 років тому
From a panel discussion with Laura Sheridan, Brian Hinman, Dan Abraham, and Bob Colao.
Whether or not to patent the startup's inventions
Переглядів 3907 років тому
A panel discussion with Vishal Misra, Greg Blonder, Matt Price, and Seth Tripper.
Putting a dollar value on patents
Переглядів 907 років тому
Part of a panel discussion with Laura Sheridan, Brian Hinman, Dan Abraham, and Bob Colao.
Standard Essential Patents & Patent Pools
Переглядів 3987 років тому
Part of a panel discussion with Laura Sheridan, Brian Hinman, Dan Abraham, and Bob Colao.
Entrepreneurs and VCs in Discussion on IP
Переглядів 497 років тому
Entrepreneurs and VCs in Discussion on IP
Venture Capital Perspectives on Intellectual Property (Full)
Переглядів 4477 років тому
Venture Capital Perspectives on Intellectual Property (Full)
Emerging business models in IP licensing IPXI; AST; License on Transfer; Google's patent purchase pr
Переглядів 2557 років тому
Emerging business models in IP licensing IPXI; AST; License on Transfer; Google's patent purchase pr
Patent licensing: in house vs outsourcing
Переглядів 1307 років тому
Patent licensing: in house vs outsourcing
Audience question: Valuing intellectual property vs the underlying technology itself
Переглядів 717 років тому
Audience question: Valuing intellectual property vs the underlying technology itself
Intellectual Property in the Fortune 500 (Full)
Переглядів 377 років тому
Intellectual Property in the Fortune 500 (Full)
Audience question: Are patent holders all just trolls?
Переглядів 177 років тому
Audience question: Are patent holders all just trolls?
Entrepreneur Perspectives on Intellectual Property (Full)
Переглядів 3177 років тому
Entrepreneur Perspectives on Intellectual Property (Full)
Patent Enforcement: Monetizing Your IP
Переглядів 2457 років тому
Patent Enforcement: Monetizing Your IP
Venture Capital Perspectives: Early Stage Biotech Investing with Doug Cole, Flagship Ventures
Переглядів 15 тис.7 років тому
Venture Capital Perspectives: Early Stage Biotech Investing with Doug Cole, Flagship Ventures
Biopharma Perspectives on Early Venture Investing and R&D
Переглядів 1,6 тис.7 років тому
Biopharma Perspectives on Early Venture Investing and R&D
Such a great video
Sir I am Dalwin, I have patent for monitization ,can you help me out. Thanks
just wow...crystal clear explanation...
Hello, do you recommend any books on the subject?
love it